GeneCode AS
Active Registry code 10362550
AS Tallinn Registered 15 Jan 1998
GeneCode AS is a AS based in Tallinn, registry code 10362550, status: active. Main activity: Research and experimental development on biotechnology. According to EMTA, turnover for Q3 2026 was €197 171 with 2 employees.
Turnover
197 171 €
↓ 62.7% vs Q2 2026
State taxes
13 150 €
↓ 14.7% vs Q2 2026
Labour taxes
23 142 €
↓ 16.0% vs Q2 2026
Employees
2
−1 vs Q2 2026
Q3 2026 · data from the Tax and Customs Board (EMTA)
Position in the industry
- Turnover · Q3 2026 197 171 €above 90% of companiesindustry median 14 442 € · companies in the industry: 318
- Labour taxes per employee 11 571 €above 98% of companiesindustry median 2 218 € · companies in the industry: 234
- Revenue · 2021 0 €above 5% of companiesindustry median 0 € · companies in the industry: 837
Taxes and turnover
- Company
- Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Quarter | Turnover, € | State taxes, € | Labour taxes, € | Employees |
|---|---|---|---|---|
| Q3 2026 | 197 171 | 13 150 | 23 142 | 2 |
| Q2 2026 | 527 913 | 15 425 | 27 536 | 3 |
| Q1 2026 | 340 723 | 7 170 | 23 186 | 3 |
| Q4 2025 | 121 470 | 15 321 | 18 236 | 3 |
| Q3 2025 | 182 550 | 19 680 | 21 645 | 3 |
| Q2 2025 | 189 346 | 8 434 | 10 123 | 3 |
| Q1 2025 | 321 410 | 9 843 | 19 811 | 3 |
| Q4 2024 | 95 338 | 16 938 | 19 148 | 3 |
| Q3 2024 | 142 219 | 7 875 | 15 908 | 3 |
| Q2 2024 | 77 325 | 4 343 | 9 428 | 2 |
| Q1 2024 | 67 839 | — | 10 422 | 2 |
| Q4 2023 | 19 867 | 8 807 | 11 948 | 3 |
| Q3 2023 | 102 960 | 9 884 | 12 073 | 3 |
| Q2 2023 | 223 918 | 8 723 | 11 948 | 3 |
| Q1 2023 | 589 044 | 10 694 | 11 842 | 3 |
| Q4 2022 | 267 048 | — | 10 881 | 3 |
| Q3 2022 | 257 587 | 9 153 | 12 302 | 3 |
| Q2 2022 | 701 877 | — | 5 847 | 3 |
| Q1 2022 | 4 604 | 1 663 | 5 462 | 3 |
Labour taxes per employee per month
3 857 €
Turnover per employee in the quarter
98 586 €
Q3 2026 · calculated from EMTA data
Financials by year
- Company
- Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Year | Revenue, € | Net profit, € | Labour costs, € | Assets, € | Equity, € | Employees |
|---|---|---|---|---|---|---|
| 2025 | — | 383 883 | 188 006 | 7 940 583 | 5 707 532 | 3 |
| 2024 | — | 508 690 | 152 132 | 6 276 586 | 5 323 649 | 3 |
| 2023 | — | 951 155 | 130 883 | 6 019 328 | 4 814 959 | 3 |
| 2022 | — | 1 262 642 | 98 642 | 4 299 237 | 3 863 805 | 3 |
| 2021 | 0 | -69 880 | 0 | 2 647 003 | 2 601 163 | 0 |
| 2020 | 4 250 | -26 692 | 0 | 2 690 379 | 1 578 603 | 0 |
| 2019 | — | -28 481 | 0 | 2 678 423 | 1 605 295 | 0 |
| 2018 | — | — | — | — | — | 0 |
| 2017 | — | — | — | — | — | 0 |
| 2016 | — | — | — | — | — | 0 |
| 2015 | — | — | — | — | — | 1 |
| 2014 | — | — | — | — | — | 1 |
| 2013 | — | — | — | — | — | 0 |
| 2012 | — | — | — | — | — | 0 |
| 2011 | — | — | — | — | — | 8 |
| 2010 | — | — | — | — | — | 9 |
| 2009 | — | — | — | — | — | 9 |
| 2008 | — | — | — | — | — | 2 |
| 2007 | — | — | — | — | — | 2 |
| 2006 | — | — | — | — | — | 1 |
| 2005 | — | — | — | — | — | 2 |
| 2004 | — | — | — | — | — | 2 |
| 2003 | — | — | — | — | — | 2 |
| 2002 | — | — | — | — | — | 2 |
| 2001 | — | — | — | — | — | 2 |
| 1998 | — | — | — | — | — | 2 |
Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.
Financial ratios for 2025
Return on equity (ROE)
6.7 %
Net profit / equity
Return on assets (ROA)
4.8 %
Net profit / assets
Equity ratio
71.9 %
Equity / assets
Debt ratio
28.1 %
Liabilities / assets
Current ratio
0.54
Current assets / current liabilities
Labour cost per employee per month
5 222 €
Labour costs / employees / 12 months (incl. employer taxes)
Annual reports
| Year | Period | Filed | Report | Documents |
|---|---|---|---|---|
| 2025 | 1 Jan 2025 – 31 Dec 2025 | 6 Jul 2026 | Company’s own · audited | e-Äriregister |
| 2024 | 1 Jan 2024 – 31 Dec 2024 | 6 Oct 2025 | Company’s own · audited | e-Äriregister |
| 2023 | 1 Jan 2023 – 31 Dec 2023 | 5 Apr 2024 | Company’s own · audited | e-Äriregister |
| 2022 | 1 Jan 2022 – 31 Dec 2022 | 20 Jun 2023 | Company’s own · audited | e-Äriregister |
| 2021 | 1 Jan 2021 – 31 Dec 2021 | 6 Jun 2022 | Company’s own · audited | e-Äriregister |
| 2020 | 1 Jan 2020 – 31 Dec 2020 | 3 Sep 2021 | Company’s own · audited | e-Äriregister |
| 2019 | 1 Jan 2019 – 31 Dec 2019 | 10 Nov 2020 | Company’s own · audited | e-Äriregister |
Commercial pledges
| No. | Amount | Pledgee | Period |
|---|---|---|---|
| 2 | 518 830 € | Finora Bank UAB | 14 Jul 2025 – in force |
Board
- Nasdaq CSD SEKeeper of the share ledger · since 28 Sep 2017
- Paavo PilvBoard member · since 26 Oct 2023
Right of representation
Any member of the management board may represent the public limited company in all transactions.
Owners
No owner information.
Beneficial owners
- Hendrik HindovIndirect ownership · since 25 Aug 2026
- Thomas Björn WaldinIndirect ownership · USA · since 25 Aug 2026
Founders and other persons
- Hendrik HindovSupervisory board member · 17 Oct 2023
- Mart SaarmaSupervisory board member · 17 Oct 2023
- Thomas Björn WaldinSupervisory board member · 17 Oct 2023
- Piia PilvSupervisory board member · 1 May 2026
- Omanikukonto: AnsonBaer Nordic OÜShareholder · 30 240 € · 16 Aug 2023
- Omanikukonto: BALTIC TECHNOLOGY LLCShareholder · 26 460 € · 16 Aug 2023
- Omanikukonto: MPPS INVESTEERINGUD OÜShareholder · 18 900 € · 16 Aug 2023
Related companies
Activities (EMTAK)
- 72111Research and experimental development on biotechnology Main
Rulings
All rulings (PDF)| Number, date | Title | Deadline | State | Document |
|---|---|---|---|---|
| Ä 10022922 / 21 7 Oct 2025 |
Amendment entry | In force 7 Oct 2025 |
||
| K 10022922 / 20 14 Jul 2025 |
Commercial pledge entered | In force 14 Jul 2025 |
||
| Ä 10022922 / M10 9 Jul 2025 |
Warning of deletion from the register: annual report not filed | 12 Oct 2025 | Deficiencies eliminated 7 Oct 2025 |
|
| Ä 10022922 / M9 20 Jan 2025 |
Ruling to correct data outside an entry | 3 Feb 2025 | In force 20 Jan 2025 |
|
| Ä 10022922 / 19 2 Nov 2023 |
Amendment under Code of Civil Procedure § 595¹ (1) | In force 2 Nov 2023 |
||
| Ä 10022922 / 18 26 Oct 2023 |
Amendment entry | In force 26 Oct 2023 |
||
| K 10022922 / 17 23 Oct 2023 |
Commercial pledge deleted | In force 23 Oct 2023 |
||
| Ä 10022922 / 16 25 Jul 2023 |
Amendment under Code of Civil Procedure § 595¹ (1) | In force 25 Jul 2023 |
||
| Ä 10022922 / 15 22 Dec 2021 |
Amendment entry | In force 22 Dec 2021 |
||
| Ä 10022922 / M8 19 Oct 2020 |
Procedural ruling | In force 19 Oct 2020 |
||
| Ä 10022922 / 14 2 Mar 2020 |
Entry refused: deficiencies not eliminated | In force 17 Mar 2020 |
||
| Ä 10022922 / M7 7 Jan 2020 |
Ruling to eliminate deficiencies | 6 Feb 2020 | In force 7 Jan 2020 |
|
| Ä 10022922 / 13 16 Jan 2018 |
Amendment entry | In force 16 Jan 2018 |
||
| Ä 10022922 / 12 7 Nov 2017 |
Amendment entry | In force 7 Nov 2017 |
||
| Ä 10022922 / 11 28 Sep 2017 |
Amendment entry | In force 28 Sep 2017 |
||
| Ä 10022922 / 10 14 Sep 2016 |
Amendment entry | In force 14 Sep 2016 |
||
| Ä 10022922 / 9 11 Feb 2015 |
Amendment entry | In force 11 Feb 2015 |
||
| Ä 10022922 / M6 6 Feb 2015 |
Ruling to eliminate deficiencies | 26 Feb 2015 | Deficiencies eliminated 11 Feb 2015 |
|
| Ä 10022922 / M5 30 Jan 2015 |
Procedural ruling | 14 Feb 2015 | Deficiencies eliminated 6 Feb 2015 |
|
| Ä 10022922 / M4 16 May 2014 |
Warning of deletion from the register: annual report not filed | 12 Nov 2014 | Deficiencies eliminated 12 Sep 2014 |
|
| Ä 10022922 / 8 6 Feb 2014 |
Amendment entry | In force 6 Feb 2014 |
||
| Ä 10022922 / M3 27 Jan 2014 |
Ruling to eliminate deficiencies | 16 Feb 2014 | Deficiencies eliminated 6 Feb 2014 |
|
| K 10162798 25 Nov 2011 |
Commercial pledge entered | In force 25 Nov 2011 |
||
| Ä 10022922 / 7 21 Sep 2011 |
Amendment entry | In force 21 Sep 2011 |
||
| Ä 10022922 / 6 24 Aug 2011 |
Amendment entry | In force 24 Aug 2011 |
||
| Ä 22922 / 5 3 Dec 2008 |
Deletion of activities from the registry card | In force 11 Dec 2008 |
||
| Ä 22922 / 4 3 Apr 2007 |
Amendment entry | In force 3 Apr 2007 |
||
| Ä 22922 / M2 29 Mar 2007 |
Ruling to eliminate deficiencies (to be served) | In force 29 Mar 2007 |
||
| Ä 22922 / 3 7 Aug 2006 |
Transformation entry without a new registry card | In force 7 Aug 2006 |
Sources: e-Äriregister and EMTA. Data updated 30 Oct 2026. Open at the source ↗ · Report an error in the data